文献速递泌尿系结石

肾结石评估中基因检测的应用:来自多学科肾结石门诊的回顾性分析

The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic.
PubMed 文献 · Urology · 2024-07-22

该回顾性分析描述了2018至2022年间在某多学科肾结石门诊接受基因检测患者的遗传与临床特征:825例就诊患者中50例转诊遗传科,33例完成检测,19例发现变异、其中9例为已知致病性变异;作者认为需进一步评估基因检测对肾结石管理的影响。

要点

  • 825例结石门诊患者中50例转诊遗传科,33例完成基因检测。
  • 33例中19例(58%)检出变异,其中9例(27%)为已知致病性变异。
  • 作者认为需进一步评估基因检测对肾结石管理的影响。

核心结论

  • 在该中心的结石门诊中,超过半数接受基因检测的患者检出变异,但多数变异意义不明。
  • 作者认为需进一步评估基因检测如何影响肾结石的管理。

研究设计与样本

  • 回顾性分析2018至2022年在该中心结石门诊评估并转诊遗传科的患者。
  • 825例结石门诊患者中50例转诊遗传科,其中33例(66%)完成基因检测并纳入分析。

主要发现

  • 完成基因检测的33例中19例(58%)检出变异,其中9/33(27%)为已知致病性变异。
  • 检出致病性变异的患者中,55.6%有结石家族史,77.8%为钙基结石。
  • 检出致病性变异的患者中,66.7%首次结石发生在18岁前,100%为复发性结石形成者。
  • 检出致病性变异的患者中,88.9%在检测前接受过药物治疗,88.9%接受过手术治疗。
  • 致病性变异组、意义不明变异组与无变异组之间,人口学或临床参数无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe genetic and clinical characteristics for patients undergoing genetic testing at our multidisciplinary kidney stone clinic. METHODS: A retrospective review was performed on patients evaluated in our stone clinic and referred to genetics between 2018 and 2022. Patient demographic, clinical, stone, and genetic data were included. We assessed the specific variants identified in our cohort, both those with a pathogenic association and variants of unknown significance. RESULTS: Of 825 patients seen in our stone clinic from 2018-2022, 50 patients were referred to genetics. Among these patients, 33/50 (66%) underwent genetic testing and were included in the analysis. Of those who underwent genetic testing, a variant was identified in 19/33 (58%) patients, and 9/33 (27%) of these were a known pathogenic variant. Among patients with a pathogenic variant identified, the majority had a family history of stones (55.6%), calcium-based stones (77.8%), had their first stone prior to age 18 (66.7%), were recurrent stone formers (100%), and had been managed medically (88.9%) or surgically (88.9%) prior to testing. When comparing patients with a pathogenic variant, variants of unknown significance, and no variant, there were no significant differences in demographic or clinical parameters. CONCLUSION: In our stone practice, more than half of patients who underwent genetic testing were found to have a variant. However, the majority of these variants were of unknown significance. Further evaluation regarding how genetic testing can impact nephrolithiasis management is needed.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Payne NG, Boddu SP, Wymer KM, et al. The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic. Urology. 2024. PMID: 39047952. doi:10.1016/j.urology.2024.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。